PT95580A - Processo para a preparacao de material biologico modificado - Google Patents

Processo para a preparacao de material biologico modificado

Info

Publication number
PT95580A
PT95580A PT95580A PT9558090A PT95580A PT 95580 A PT95580 A PT 95580A PT 95580 A PT95580 A PT 95580A PT 9558090 A PT9558090 A PT 9558090A PT 95580 A PT95580 A PT 95580A
Authority
PT
Portugal
Prior art keywords
species
rejection
complement
preparation
biological material
Prior art date
Application number
PT95580A
Other languages
English (en)
Other versions
PT95580B (pt
Inventor
David James Graham White
Alan Frederick Williams
Original Assignee
Imutran Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26296038&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT95580(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB898922987A external-priority patent/GB8922987D0/en
Priority claimed from GB909017198A external-priority patent/GB9017198D0/en
Application filed by Imutran Ltd filed Critical Imutran Ltd
Publication of PT95580A publication Critical patent/PT95580A/pt
Publication of PT95580B publication Critical patent/PT95580B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0278—Knock-in vertebrates, e.g. humanised vertebrates
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0271—Chimeric vertebrates, e.g. comprising exogenous cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/15—Humanized animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/108—Swine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/02—Animal zootechnically ameliorated
    • A01K2267/025—Animal producing cells or organs for transplantation
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Environmental Sciences (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Animal Husbandry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Transplantation (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
PT95580A 1989-10-12 1990-10-12 Processo para a preparacao de material biologico modificado PT95580B (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898922987A GB8922987D0 (en) 1989-10-12 1989-10-12 Modified biological material
GB909017198A GB9017198D0 (en) 1990-08-06 1990-08-06 Modified biological material

Publications (2)

Publication Number Publication Date
PT95580A true PT95580A (pt) 1991-09-13
PT95580B PT95580B (pt) 1999-05-31

Family

ID=26296038

Family Applications (2)

Application Number Title Priority Date Filing Date
PT95580A PT95580B (pt) 1989-10-12 1990-10-12 Processo para a preparacao de material biologico modificado
PT101896A PT101896B (pt) 1989-10-12 1996-07-15 MATERIAL BIOLóGICO MODIFICADO, NOMEADAMENTE UM ANIMAL TRANSGéNICO, E MéTODO DE TRANSPLANTE, DE TECIDO ANIMAL

Family Applications After (1)

Application Number Title Priority Date Filing Date
PT101896A PT101896B (pt) 1989-10-12 1996-07-15 MATERIAL BIOLóGICO MODIFICADO, NOMEADAMENTE UM ANIMAL TRANSGéNICO, E MéTODO DE TRANSPLANTE, DE TECIDO ANIMAL

Country Status (27)

Country Link
US (1) US6495735B1 (pt)
EP (2) EP0495852B1 (pt)
JP (1) JP3302358B2 (pt)
KR (2) KR100317106B1 (pt)
CN (2) CN1122719C (pt)
AT (1) ATE139562T1 (pt)
AU (1) AU654116B2 (pt)
BG (1) BG61080B1 (pt)
CA (1) CA2067235A1 (pt)
CY (1) CY1996A (pt)
DE (2) DE69027535T2 (pt)
DK (1) DK0495852T3 (pt)
ES (1) ES2060561T3 (pt)
FI (1) FI921618A0 (pt)
GR (2) GR940300004T1 (pt)
HK (1) HK48497A (pt)
HU (1) HUT64584A (pt)
IE (1) IE75345B1 (pt)
IL (2) IL95970A0 (pt)
IN (1) IN171948B (pt)
MY (1) MY107433A (pt)
NO (2) NO303502B1 (pt)
NZ (2) NZ235657A (pt)
PT (2) PT95580B (pt)
RO (1) RO109863B1 (pt)
SG (1) SG72614A1 (pt)
WO (1) WO1991005855A1 (pt)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5705732A (en) * 1989-06-12 1998-01-06 Oklahoma Medical Research Foundation Universal donor cells
EP0483247A4 (en) * 1989-07-21 1992-12-09 Washington University Recombinantly produced human membrane cofactor protein (mcp)
CA2082277A1 (en) * 1990-05-11 1991-11-12 Damien F. J. Purcell Cd46 variants
US5846715A (en) * 1990-05-11 1998-12-08 The Austin Research Institute CD46 variants
ATE237682T1 (de) * 1991-07-15 2003-05-15 Oklahoma Med Res Found Universale spenderzellen
US6916654B1 (en) * 1992-06-29 2005-07-12 Oklahoma Medical Research Foundation Universal donor cells
EP0662125A1 (en) * 1992-09-22 1995-07-12 Dnx Biotherapeutics, Inc. Delivery of proteins by intermembrane transfer for preaccommodation of xenogeneic organ transplants and other purposes
US5627264A (en) * 1994-03-03 1997-05-06 Alexion Pharmaceuticals, Inc. Chimeric complement inhibitor proteins
AU711183B2 (en) * 1994-08-19 1999-10-07 Biotransplant Incorporated Genetically engineered swine cells
AU723003C (en) * 1995-08-04 2004-01-29 General Hospital Corporation, The Transgenic swine and swine cells having human HLA genes
US6166288A (en) * 1995-09-27 2000-12-26 Nextran Inc. Method of producing transgenic animals for xenotransplantation expressing both an enzyme masking or reducing the level of the gal epitope and a complement inhibitor
AU1933897A (en) * 1996-03-22 1997-10-17 Imutran Limited Surfaces which prevent or reduce complement activation
NZ500007A (en) 1997-03-26 2001-08-31 Imp College Innovations Ltd Anticoagulant fusion protein anchored to cell membrane to prevent organ rejection after a transplant
US6825395B1 (en) 1997-07-14 2004-11-30 Nippon Meat Packers, Inc. Transgenic non-human mammals expressing the human complement inhibitor (DAF/CD55)
EP0996461B1 (en) * 1997-10-31 2005-01-12 Walter Reed Army Institute of Research Use of a complement activation inhibitor in the manufacture of a medicament for inhibiting side effects of pharmaceutical compositions containing amphiphilic vehicles or drug carrier molecules
SE523817C2 (sv) 1999-02-05 2004-05-18 Corline Systems Ab Användning av ett koagulationsförebyggande ämne i samband med transplantation av insulinproducerande celler
GB9905503D0 (en) 1999-03-10 1999-05-05 Adprotech Plc Novel compound formulations and methods of delivery
WO2005009134A1 (en) * 2003-07-21 2005-02-03 Lifecell Corporation ACELLULAR TISSUE MATRICES MADE FROM GALACTOSE α-1,3-GALACTOSE-DEFICIENT TISSUE
NZ810903A (en) 2009-08-14 2024-08-30 Revivicor Inc Multi-transgenic pigs for diabetes treatment
US9420770B2 (en) 2009-12-01 2016-08-23 Indiana University Research & Technology Corporation Methods of modulating thrombocytopenia and modified transgenic pigs
NZ608814A (en) 2010-09-03 2015-06-26 Stem Centrx Inc Novel modulators and methods of use
ES2680636T3 (es) 2011-02-14 2018-09-10 Revivicor Inc. Cerdos genéticamente modificados para xenotrasplante de xenoinjertos vascularizados y derivados de los mismos
AU2014341866B2 (en) 2013-11-04 2018-07-05 Lifecell Corporation Methods of removing alpha-galactose
CN114686427B (zh) * 2022-05-23 2022-07-29 中国人民解放军总医院第一医学中心 一种脾脏调节型b淋巴细胞及其制备方法与应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0081570A4 (en) * 1981-06-12 1985-09-02 Univ Ohio GENETIC TRANSFORMATION OF ZYGOTS.
US4431636A (en) 1982-05-24 1984-02-14 American Cyanamid Company Bis(4-O-polyhexaose-thio)-phenyl ureas and method of use
US5109113A (en) * 1986-05-02 1992-04-28 Genentech, Inc. Membrane anchor fusion polypeptides
JPS62104594A (ja) * 1985-10-31 1987-05-15 Terumo Corp クエン酸塩利用能検査用培地組成物
JPH0742235B2 (ja) * 1985-11-08 1995-05-10 三共株式会社 自己免疫性疾病の予防・治療剤
IL82390A0 (en) * 1986-05-02 1987-10-30 Genentech Inc Nucleic acid and methods for the synthesis of novel daf compositions
GB8615942D0 (en) * 1986-06-30 1986-08-06 Animal & Food Research Council Peptide production
IL89790A (en) * 1988-04-01 2002-05-23 Johns Hopking University Sequences of nucleic acids encoding and cells producing CR1 protein and methods for its production and purification
DE3830271A1 (de) 1988-09-06 1990-03-15 Goetze Otto Mittel mit immunsuppressiver wirkung
US5573940A (en) * 1989-06-12 1996-11-12 Oklahoma Medical Research Foundation Cells expressing high levels of CD59

Also Published As

Publication number Publication date
ES2060561T1 (es) 1994-12-01
CN1122719C (zh) 2003-10-01
CN1051199A (zh) 1991-05-08
JPH05503074A (ja) 1993-05-27
IL120795A0 (en) 1997-09-30
IE903649A1 (en) 1991-04-24
DK0495852T3 (da) 1996-07-15
NZ248153A (en) 1997-07-27
PT101896B (pt) 2003-01-31
WO1991005855A1 (en) 1991-05-02
NO921438D0 (no) 1992-04-10
HU9201240D0 (en) 1992-06-29
FI921618A (fi) 1992-04-10
NO982131D0 (no) 1998-05-11
NZ235657A (en) 1994-05-26
AU654116B2 (en) 1994-10-27
GR940300004T1 (en) 1994-02-28
ES2060561T3 (es) 1996-08-01
ATE139562T1 (de) 1996-07-15
BG61080B1 (bg) 1996-10-31
NO303502B1 (no) 1998-07-20
BG96329A (bg) 1993-12-24
CA2067235A1 (en) 1991-04-13
DE69027535D1 (de) 1996-07-25
AU6539290A (en) 1991-05-16
GR3020741T3 (en) 1996-11-30
IN171948B (pt) 1993-02-13
PT95580B (pt) 1999-05-31
NO921438L (no) 1992-04-10
EP0709459A2 (en) 1996-05-01
HUT64584A (en) 1994-01-28
NO982131L (no) 1992-04-10
FI921618A0 (fi) 1992-04-10
EP0709459A3 (en) 1999-01-07
IE75345B1 (en) 1997-08-27
EP0495852A1 (en) 1992-07-29
CY1996A (en) 1997-09-05
MY107433A (en) 1995-12-30
US6495735B1 (en) 2002-12-17
KR100317106B1 (ko) 2001-12-22
KR920702410A (ko) 1992-09-04
HK48497A (en) 1997-04-25
CN1491624A (zh) 2004-04-28
DE69027535T2 (de) 1996-11-28
SG72614A1 (en) 2000-05-23
IL95970A0 (en) 1992-05-25
PT101896A (pt) 1998-02-27
JP3302358B2 (ja) 2002-07-15
EP0495852B1 (en) 1996-06-19
RO109863B1 (ro) 1995-06-30
DE495852T1 (de) 1994-03-31

Similar Documents

Publication Publication Date Title
PT95580A (pt) Processo para a preparacao de material biologico modificado
ES2057027T3 (es) Un procedimiento para preparar un compuesto macrolido.
ATE339207T1 (de) Verwendung von taurolidin oder taurultam zur herstellung eines medikaments zur behandlung von ovarialkarzinomen
KR930021061A (ko) 살충방법
AR018489A1 (es) Uso de una celula realizada geneticamente que comprende dna que codifica una proteina de gen de activacion de linfocito 3 (lag-3) transmembrana y de dicha proteina para la fabricacion de un medicamento util para inducir la proteccion del rechazo de injerto y uso de moleculas antisentido de las misma
DK0410319T3 (da) Middel til spirogyrabekæmpelse og desodorisering
PT97277A (pt) Processo para a preparacao de formulacoes farmaceuticas, contendo, por exemplo, ciclosporina a e factor de veneno de cobracapelo, uteis para a inibicao da rejeicao de aloenxerto e de xenoenxerto concordante
BR9004494A (pt) Composto,processo para prevencao,tratamento ou controle de infeccao endoparasitica ou ectoparasitica,processo para proteger culturas,arvores,arbustos,graos armaenados e plantas ornamentais do ataque por insetos,acaros e nematodeos e composicao para controlar endo e ectoparasitos,insetos,acaros e nematodeos
DE69034147D1 (de) Verfahren zur Desinfektion von Knochengeweben
DK405983D0 (da) Biologiske ukrudtsbekaempelsesmidler
PT94838A (pt) Processo para a preparacao de beta-tioacrilamidas s-substituidas e de composicoes microbicidas que as contem
RU2006111449A (ru) Способ получения средства из личинок мух для лечения ран, и средство, полученное этим способом
DE59308555D1 (de) Vorrichtung für eine Entalkoholisierungsanlage
AR008645A1 (es) MEZCLAS SoLIDAS EN BASE A UNA SAL DEL 2,2-DIoXIDO DE 3-ISOPROPIL-2,1,3- BENZOTIADIAZíN-4-ONA, uTILES PARA CONTROLAR EL CRECIMIENTO DE LAS PLANTAS INDESEADAS, PROCEDIMIENTO DE PREPARACIoN Y APLICACIoN.
Turillazzi Distinguishing features of the social behaviour of Stenogastrinae wasps.
TR26704A (tr) Muamele edilmis kullanim disi tohumun kullanilir hale getirilmesi.
ATE255908T1 (de) Immunotoxinmischungen zur behandlung von immunkrankheiten.
Chang et al. An In-vitro Experimental Study on Antibacerial Effects of Antibiotic-mixed Plaster of Paris Pellets
CZ3042U1 (cs) Kruhovitý korpus pro hotovení věnců

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19910401

FG3A Patent granted, date of granting

Effective date: 19990201

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20070801